637 related articles for article (PubMed ID: 26969309)
1. Genetic counseling and cascade genetic testing in Lynch syndrome.
Hampel H
Fam Cancer; 2016 Jul; 15(3):423-7. PubMed ID: 26969309
[TBL] [Abstract][Full Text] [Related]
2. Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing.
Frolova AI; Babb SA; Zantow E; Hagemann AR; Powell MA; Thaker PH; Gao F; Mutch DG
Gynecol Oncol; 2015 Apr; 137(1):7-13. PubMed ID: 25617771
[TBL] [Abstract][Full Text] [Related]
3. Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer.
Lee J; Gubernick LR; Brodsky AL; Fehniger JE; Levine DA; Gerber D; Asgari SA; Cantor A; Martineau JT; Ginsburg OM; Smith JA; Pothuri B
Gynecol Oncol; 2018 Oct; 151(1):153-158. PubMed ID: 30077346
[TBL] [Abstract][Full Text] [Related]
4. Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center.
Moline J; Mahdi H; Yang B; Biscotti C; Roma AA; Heald B; Rose PG; Michener C; Eng C
Gynecol Oncol; 2013 Jul; 130(1):121-6. PubMed ID: 23612316
[TBL] [Abstract][Full Text] [Related]
5. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of Lynch syndrome in women with endometrial cancer: a systematic review protocol.
Ryan NAJ; Blake D; Cabrera-Dandy M; Glaire MA; Evans DG; Crosbie EJ
Syst Rev; 2018 Aug; 7(1):121. PubMed ID: 30115102
[TBL] [Abstract][Full Text] [Related]
7. Endometrial cancer and Lynch syndrome: clinical and pathologic considerations.
Meyer LA; Broaddus RR; Lu KH
Cancer Control; 2009 Jan; 16(1):14-22. PubMed ID: 19078925
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of screening strategies for Lynch syndrome.
Barzi A; Sadeghi S; Kattan MW; Meropol NJ
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25794514
[TBL] [Abstract][Full Text] [Related]
9. Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.
Cohen SA; Laurino M; Bowen DJ; Upton MP; Pritchard C; Hisama F; Jarvik G; Fichera A; Sjoding B; Bennett RL; Naylor L; Jacobson A; Burke W; Grady WM
Cancer; 2016 Feb; 122(3):393-401. PubMed ID: 26480326
[TBL] [Abstract][Full Text] [Related]
10. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA
Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409
[TBL] [Abstract][Full Text] [Related]
11. Targeted Screening With Combined Age- and Morphology-Based Criteria Enriches Detection of Lynch Syndrome in Endometrial Cancer.
Lin DI; Hecht JL
Int J Surg Pathol; 2016 Jun; 24(4):297-305. PubMed ID: 26842347
[TBL] [Abstract][Full Text] [Related]
12. Targeted Next-Generation Sequencing for Hereditary Cancer Syndromes: A Focus on Lynch Syndrome and Associated Endometrial Cancer.
Tafe LJ
J Mol Diagn; 2015 Sep; 17(5):472-82. PubMed ID: 26162329
[TBL] [Abstract][Full Text] [Related]
13. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.
Ladabaum U; Wang G; Terdiman J; Blanco A; Kuppermann M; Boland CR; Ford J; Elkin E; Phillips KA
Ann Intern Med; 2011 Jul; 155(2):69-79. PubMed ID: 21768580
[TBL] [Abstract][Full Text] [Related]
14. Patterns of germline and somatic testing after universal tumor screening for Lynch syndrome: A clinical practice survey of active members of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.
Hodan R; Rodgers-Fouche L; Arora S; Dominguez-Valentin M; Kanth P; Katona BW; Mraz KA; Roberts ME; Vilar E; Soto-Azghani CM; Brand RE; Esplin ED; Perez K
J Genet Couns; 2022 Aug; 31(4):949-955. PubMed ID: 35218578
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of screening endometrial cancer patients for Lynch syndrome by patient-administered checklist.
Daniels MS; Urbauer DL; Zangeneh A; Batte BA; Dempsey KM; Lu KH
Gynecol Oncol; 2013 Dec; 131(3):619-23. PubMed ID: 24141004
[TBL] [Abstract][Full Text] [Related]
16. [Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].
Schneider R; Schneider C; Büttner R; Reinacher-Schick A; Tannapfel A; Fürst A; Rüschoff J; Jakobeit C; Royer-Pokora B; Möslein G
Zentralbl Chir; 2015 Dec; 140(6):591-9. PubMed ID: 25372301
[TBL] [Abstract][Full Text] [Related]
17. Gynecologic Cancers in Lynch Syndrome/HNPCC.
Lu KH; Broaddus RR
Fam Cancer; 2005; 4(3):249-54. PubMed ID: 16136386
[TBL] [Abstract][Full Text] [Related]
18. Lynch syndrome.
Backes FJ; Cohn DE
Clin Obstet Gynecol; 2011 Jun; 54(2):199-214. PubMed ID: 21508689
[TBL] [Abstract][Full Text] [Related]
19. Follow-up recommendations and risk-reduction initiatives for Lynch syndrome.
Guillén-Ponce C; Molina-Garrido MJ; Carrato A
Expert Rev Anticancer Ther; 2012 Oct; 12(10):1359-67. PubMed ID: 23176623
[TBL] [Abstract][Full Text] [Related]
20. Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: Implications for genetic counselling.
Johnatty SE; Tan YY; Buchanan DD; Bowman M; Walters RJ; Obermair A; Quinn MA; Blomfield PB; Brand A; Leung Y; Oehler MK; ; Kirk JA; O'Mara TA; Webb PM; Spurdle AB
Gynecol Oncol; 2017 Nov; 147(2):381-387. PubMed ID: 28822557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
